Zealthy offers FDA-approved treatments tailored to specific hair loss patterns. Its combination of Finasteride and Minoxidil gel produces powerful results for overall thinning, with 90% of users ...

Key Takeaways Finasteride may not be an effective option for some individuals and dutasteride may be a solid alternative.

It’s the first of a new class of analgesics to be approved in over 20 years, and, importantly, it isn’t addictive. On the 30th of January 2025, the FDA approved 50-mg tablets of the novel ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection in the thigh, stomach or arm — is a brand name for ...

Similarly, an Amazon shopper noticed a "significant difference" in their “thin and wispy” hairline that’s now thicker after ...

FDA approval of PATHWAY HER2 (4B5) test expands diagnostic capabilities for HER2-ultralow metastatic breast cancer, enabling targeted treatment with trastuzumab deruxtecan. HER2-ultralow ...

Copyright 2025 The Associated Press. All Rights Reserved. U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin ...